Johnson & Johnson and CSIR-IMTECH partner to discover new tuberculosis treatments

Johnson& Johnson ’s India-based business has signed a memorandum of understanding (MoU) with the Institute of Microbial Technology (IMTECH) to discover and develop new treatments for tuberculosis (TB).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news